Stephen G. Wagner, M.D., FACC

Stephen G. Wagner, M.D., FACC

Stephen G. Wagner, M.D.

Stephen G. Wagner, M.D., FACC

  • Associate Professor of Medicine
  • Chief of Cardiology, Robley Rex Veterans Affairs Medical Center
  • Director, Nuclear Cardiology Program
University of Louisville Health Care Outpatient Center
401 East Chestnut Street, Ste. 310
Louisville, KY 40202

502-852-7959 - Academic Office
502-588-4600 - Patient Appointments


Clinical Expertise
General, Non-Invasive Cardiology; Nuclear Cardiology; Preventive Cardiology

 

Board Certifications

  • American Board of Internal Medicine -
    Internal Medicine / Cardiovascular Disease
  • Certification Council of Nuclear Cardiology

Education and Training

  • Medical School: University of Rochester
  • Residency: Georgetown University Hospital; University of California at San Francisco Medical Center
  • Fellowship: Pacific Medical Center, San Francisco

 

Recent Publications

  • Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011 Nov 26;378(9806):1847-57. doi: 10.1016/S0140-6736(11)61590-0. Epub 2011 Nov 14. PubMed PMID: 22088800.

  • Bloomfield Rubins H, Davenport J, Babikian V, Brass LM, Collins D, Wexler L, Wagner S, Papademetriou V, Rutan G, Robins SJ; VA-HIT Study Group. Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation. 2001 Jun 12;103(23):2828-33. PubMed PMID: 11401940.

  • Stoddard MF, Wagner SG, Ikram S, Longaker RA, Prince CR. Effects of nifedipine and nitroglycerin on left ventricular systolic dysfunction and impaired diastolic filling after exercise-induced ischemia in humans. J Am Coll Cardiol. 1996 Oct;28(4):915-23. PubMed PMID: 8837569.

  • Hobbs GA, Wagner SG, Levinson SS. Relationships between triglycerides, lipoproteins, glucose and coronary artery disease. Clin Chim Acta. 1995 Jun 30;238(1):59-70. PubMed PMID: 7554296.

  • Hasnie AM, Stoddard MF, Gleason CB, Wagner SG, Longaker RA, Pierangeli S, Harris EN. Diastolic dysfunction is a feature of the antiphospholipid syndrome. Am Heart J. 1995 May;129(5):1009-13. PubMed PMID: 7732958.

  • Stoddard MF, Prince CR, Tuman WL, Wagner SG. Angle of incidence does not affect accuracy of mitral stenosis area calculation by pressure half-time: application to Doppler transesophageal echocardiography. Am Heart J. 1994 Jun;127(6):1562-72. PubMed PMID: 8197984.

  • Levinson SS, Wagner SG. The relative usefulness of automated apolipoprotein A-I and high-density lipoprotein cholesterol assays as markers for coronary artery disease. Am J Clin Pathol. 1994 Jan;101(1):104-8. PubMed PMID: 8279444.

  • Levinson SS, Wagner SG. Immunonephelometric/turbidimetric apolipoprotein B assays for the clinical laboratory. Clin Chim Acta. 1993 Dec 31;223(1-2):31-42. PubMed PMID: 8143368.

  • Gleason CB, Stoddard MF, Wagner SG, Longaker RA, Pierangeli S, Harris EN. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J. 1993 Apr;125(4):1123-9. PubMed PMID: 8465738.

  • Levinson SS, Wagner SG. Measurement of apolipoprotein B-containing lipoproteins for routine clinical laboratory use in cardiovascular disease. Arch Pathol Lab Med. 1992 Dec;116(12):1350-4. PubMed PMID: 1456883.